Nordimet

Country: Evrópusambandið

Tungumál: enska

Heimild: EMA (European Medicines Agency)

Kauptu það núna

Vara einkenni Vara einkenni (SPC)
31-10-2019
Opinber matsskýrsla Opinber matsskýrsla (PAR)
31-10-2019

Virkt innihaldsefni:

Methotrexate

Fáanlegur frá:

Nordic Group B.V.

ATC númer:

L04AX03

INN (Alþjóðlegt nafn):

methotrexate

Meðferðarhópur:

Antineoplastic agents,

Lækningarsvæði:

Arthritis, Psoriatic, Psoriasis, Arthritis, Juvenile Rheumatoid, Arthritis, Rheumatoid

Ábendingar:

Nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate,severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids, and severe psoriatic arthritis in adult patients.

Vörulýsing:

Revision: 9

Leyfisstaða:

Authorised

Leyfisdagur:

2016-08-17

Upplýsingar fylgiseðill

                                135
B. PACKAGE LEAFLET
136
PACKAGE LEAFLET: INFORMATION FOR THE USER
NORDIMET 7.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
NORDIMET 10 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
NORDIMET 12.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
NORDIMET 15 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
NORDIMET 17.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
NORDIMET 20 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
NORDIMET 22.5 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
NORDIMET 25 MG SOLUTION FOR INJECTION IN PRE-FILLED PEN
methotrexate
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm
them, even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Nordimet is and what it is used for
2.
What you need to know before you use Nordimet
3.
How to use Nordimet
4.
Possible side effects
5.
How to store Nordimet
6.
Contents of the pack and other information
1.
WHAT NORDIMET IS AND WHAT IT IS USED FOR
Nordimet contains the active substance methotrexate which works by:
-
reducing inflammation or swelling, and
- reducing the activity of the immune system (the body’s own defense
mechanism). An
overactive immune system has been linked to inflammatory diseases.
Nordimet is a medicine used to treat a range of inflammatory diseases:
-
active rheumatoid arthritis in adults. Active rheumatoid arthritis is
an inflammatory condition
that affects the joints;
-
severe, active juvenile idiopathic arthritis in five or more joints
(the condition is therefore
called polyarthritic), in patients who have had an inadequate response
to nonsteroidal
anti-inflammatory drugs (NSAIDs);
-
a severe fo
                                
                                Lestu allt skjalið
                                
                            

Vara einkenni

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1
NAME OF THE MEDICINAL PRODUCT
Nordimet 7.5 mg solution for injection in pre-filled pen
Nordimet 10 mg solution for injection in pre-filled pen
Nordimet 12.5 mg solution for injection in pre-filled pen
Nordimet 15 mg solution for injection in pre-filled pen
Nordimet 17.5 mg solution for injection in pre-filled pen
Nordimet 20 mg solution for injection in pre-filled pen
Nordimet 22.5 mg solution for injection in pre-filled pen
Nordimet 25 mg solution for injection in pre-filled pen
Nordimet 7.5 mg solution for injection in pre-filled syringe
Nordimet 10 mg solution for injection in pre-filled syringe
Nordimet 12.5 mg solution for injection in pre-filled syringe
Nordimet 15 mg solution for injection in pre-filled syringe
Nordimet 17.5 mg solution for injection in pre-filled syringe
Nordimet 20 mg solution for injection in pre-filled syringe
Nordimet 22.5 mg solution for injection in pre-filled syringe
Nordimet 25 mg solution for injection in pre-filled syringe
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml of solution contains 25 mg of methotrexate.
Nordimet 7.5 mg solution for injection in pre-filled pen
Each pre-filled pen contains 7.5 mg methotrexate in 0.3 mL
Nordimet 10 mg solution for injection in pre-filled pen
Each pre-filled pen contains 10 mg methotrexate in 0.4 mL
Nordimet 12.5 mg solution for injection in pre-filled pen
Each pre-filled pen contains 12.5 mg methotrexate in 0.5 mL
Nordimet 15 mg solution for injection in pre-filled pen
Each pre-filled pen contains 15 mg methotrexate in 0.6 mL
Nordimet 17.5 mg solution for injection in pre-filled pen
Each pre-filled pen contains 17.5 mg methotrexate in 0.7 mL
Nordimet 20 mg solution for injection in pre-filled pen
Each pre-filled pen contains 20 mg methotrexate in 0.8 mL
Nordimet 22.5 mg solution for injection in pre-filled pen
Each pre-filled pen contains 22.5 mg methotrexate in 0.9 mL
Nordimet 25 mg solution for injection in pre-filled pen
Each pre-filled pen contains 25 mg methotrexate in 1.0 mL
Nordime
                                
                                Lestu allt skjalið
                                
                            

Skjöl á öðrum tungumálum

Upplýsingar fylgiseðill Upplýsingar fylgiseðill búlgarska 29-02-2024
Vara einkenni Vara einkenni búlgarska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla búlgarska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill spænska 29-02-2024
Vara einkenni Vara einkenni spænska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla spænska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill tékkneska 29-02-2024
Vara einkenni Vara einkenni tékkneska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla tékkneska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill danska 29-02-2024
Vara einkenni Vara einkenni danska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla danska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill þýska 29-02-2024
Vara einkenni Vara einkenni þýska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla þýska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill eistneska 29-02-2024
Vara einkenni Vara einkenni eistneska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla eistneska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill gríska 29-02-2024
Vara einkenni Vara einkenni gríska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla gríska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill franska 29-02-2024
Vara einkenni Vara einkenni franska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla franska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ítalska 29-02-2024
Vara einkenni Vara einkenni ítalska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla ítalska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill lettneska 29-02-2024
Vara einkenni Vara einkenni lettneska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla lettneska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill litháíska 29-02-2024
Vara einkenni Vara einkenni litháíska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla litháíska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill ungverska 29-02-2024
Vara einkenni Vara einkenni ungverska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla ungverska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill maltneska 29-02-2024
Vara einkenni Vara einkenni maltneska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla maltneska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill hollenska 29-02-2024
Vara einkenni Vara einkenni hollenska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla hollenska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill pólska 29-02-2024
Vara einkenni Vara einkenni pólska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla pólska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill portúgalska 29-02-2024
Vara einkenni Vara einkenni portúgalska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla portúgalska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill rúmenska 29-02-2024
Vara einkenni Vara einkenni rúmenska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla rúmenska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvakíska 29-02-2024
Vara einkenni Vara einkenni slóvakíska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla slóvakíska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill slóvenska 29-02-2024
Vara einkenni Vara einkenni slóvenska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla slóvenska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill finnska 29-02-2024
Vara einkenni Vara einkenni finnska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla finnska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill sænska 29-02-2024
Vara einkenni Vara einkenni sænska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla sænska 20-11-2023
Upplýsingar fylgiseðill Upplýsingar fylgiseðill norska 29-02-2024
Vara einkenni Vara einkenni norska 29-02-2024
Upplýsingar fylgiseðill Upplýsingar fylgiseðill íslenska 29-02-2024
Vara einkenni Vara einkenni íslenska 29-02-2024
Upplýsingar fylgiseðill Upplýsingar fylgiseðill króatíska 29-02-2024
Vara einkenni Vara einkenni króatíska 29-02-2024
Opinber matsskýrsla Opinber matsskýrsla króatíska 20-11-2023

Leitaðu viðvaranir sem tengjast þessari vöru

Skoða skjalasögu